China’s Joinn Lab Expects Profit to More Than Triple in 2025 Amid Rising Lab Monkey Prices
I'm PortAI, I can summarize articles.
Joinn Laboratories, China's largest non-clinical research organization, anticipates a net profit increase of over 300% in 2025, driven by rising lab monkey prices. The net profit is projected to surge between CNY233 million and CNY349 million, despite a revenue decline of 14% to 22%, estimated at CNY1.6 billion to CNY1.7 billion. The price of lab monkeys, crucial for drug research, has rebounded to CNY140,000 per specimen due to a recovery in the pharmaceutical market and increased licensing deals for innovative drugs.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Yicai The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments